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Abstract
Background: DNA methylation plays a vital role in normal cellular function, with aberrant
methylation signatures being implicated in a growing number of human pathologies and complex
human traits. Methods based on the modification of genomic DNA with sodium bisulfite are
considered the 'gold-standard' for DNA methylation profiling on genomic DNA; however, they
require relatively large amounts of DNA and may be prohibitively expensive when used on the large
sample sizes necessary to detect small effects. We propose that a high-throughput DNA pooling
approach will facilitate the use of emerging methylomic profiling techniques in large samples.
Results: Compared with data generated from 89 individual samples, our analysis of 205 CpG sites
spanning nine independent regions of the genome demonstrates that DNA pools can be used to
provide an accurate and reliable quantitative estimate of average group DNA methylation.
Comparison of data generated from the pooled DNA samples with results averaged across the
individual samples comprising each pool revealed highly significant correlations for individual CpG
sites across all nine regions, with an average overall correlation across all regions and pools of 0.95
(95% bootstrapped confidence intervals: 0.94 to 0.96).
Conclusion: In this study we demonstrate the validity of using pooled DNA samples to accurately
assess group DNA methylation averages. Such an approach can be readily applied to the assessment
of disease phenotypes reducing the time, cost and amount of DNA starting material required for
large-scale epigenetic analyses.
Background
Epigenetics refers to the reversible regulation of various
genomic functions mediated through partially stable
modifications of DNA and chromatin histones. Epige-
netic processes are essential for normal cellular develop-
ment and differentiation, and allow the regulation of gene
function through non-mutagenic mechanisms. Of partic-
ular interest is the phenomenon of cytosine methylation,
occurring at position 5 of the cytosine pyrimidine ring in
CpG dinucleotides. This process is intrinsically linked to
the regulation of gene expression, with many genes dem-
onstrating an inverse correlation between the degree of
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DNA methylation and the level of expression [1]. The
methylation of these CpG sites, over-represented in CpG
islands in the promoter regulatory regions of many genes,
disrupts the binding of transcription factors and attracts
methyl-binding proteins that are associated with gene
silencing and chromatin compaction. DNA methylation
plays a vital role in normal cellular function, and aberrant
methylation signatures have thus been implicated in a
growing number of human pathologies [2,3] including
cancer [4], imprinting disorders [5], and even complex
neuropsychiatric phenotypes such as schizophrenia and
bipolar disorder [6]. The 'gold standard' method for map-
ping methylated cytosines is via the treatment of genomic
DNA with sodium bisulfite; this process converts unmeth-
ylated cytosines to uracils (and subsequently, via PCR, to
thymidines), while methylated cytosines are resistant to
bisulfite and remain unchanged [7]. After sodium
bisulfite treatment, DNA regions of interest are amplified
and interrogated to identify C → T transitions or stable C
positions, respectively corresponding to unmethylated
and methylated cytosines in the native DNA. Numerous
methods of analyzing bisulfite-modified DNA have been
described [8], including methods based on the sequenc-
ing of bisulfite PCR amplicons (to obtain a strand-specific
average) or the sequencing of cloned amplicons (to pro-
vide methylation maps of single DNA molecules).
Recently, several high-throughput methodologies have
been developed to determine DNA methylation patterns
from bisulfite-converted DNA templates including base-
specific cleavage followed by MALDI-TOF mass spectrom-
etry [9], and the use of next-generation deep-sequencing
methodologies to enable the highly parallel analysis of
bisulfite-treated samples [10]. Such highly quantitative
DNA methylation analyses are clearly vital to our under-
standing of gene function and the role of epigenetic dys-
function in disease, but wisdom gained following recent
large-scale genetic association studies suggests that
extremely large sample sizes may be crucial in detecting
the small effects expected in the highly complex disorders
that contribute most to the global burden of disease [11].
The expense of such large-scale research remains prohibi-
tive to many researchers, and this economic obstacle is
bolstered further by the relatively large quantities of DNA
required for bisulfite treatment, especially if multi-locus
or whole-genome approaches are to be utilized, and by
the fact that quantitative DNA methylation assessment,
unlike genotypic assessment, requires technical replicates
to ensure accuracy. Whilst the systematic assessment of
DNA methylation has the potential to revolutionize our
knowledge about the etiology of many complex disorders,
current methods remain unsuitable for profiling the large
sample cohorts likely to be required to detect pathogenic
epimutations, especially for complex disorders or where
multiple tissue types need to be assessed.
Validated pooling techniques are widely employed to
increase throughput in studies of DNA sequence variation
[12,13] and gene expression [14], and have allowed
researchers to assess samples of sizes which would other-
wise be economically infeasible. To date, however, few
studies have systematically analyzed the applicability of
DNA pooling for the analysis of DNA methylation.
Dejeux and colleagues successfully used pyrosequencing
to screen DNA methylation across five loci in pooled DNA
samples [15]. However, by pooling samples subsequent
to sodium bisulfite treatment, their approach is poten-
tially affected by differential bisulfite conversion biases,
and requires relatively large amounts of starting material
from each sample. Furthermore, the accuracy of their
pooling approach was only tested in pools comprising rel-
atively small numbers of samples, although it is likely that
much larger sample sizes will be required in etiological
studies of complex disease phenotypes. We propose that a
high-throughput DNA pooling approach would permit
many more researchers to move into epigenetic analysis,
and facilitate the use of emerging methylomic profiling
techniques in large samples.
In this study we quantitatively assessed DNA methylation
levels at 205 CpG sites across nine independent genomic
regions in four DNA pools and for each of the 89 individ-
ual samples included in the pools, to provide the first sys-
tematic investigation of the utility of DNA pooling for
bisulfite-based DNA methylation profiling experiments.
Methods
DNA pool construction
We obtained 89 high-quality Centre de'Etude du Poly-
morphism Humain (CEPH) genomic DNA samples
extracted from transformed lymphoblastoid cell lines
(Coriell Institute for Medical Research, NJ, USA). All sam-
ples were tested for degradation and quantified in tripli-
cate using fluorimetry, employing PicoGreen® dsDNA
quantitation reagent (Cambridge Bioscience, UK). Aliq-
uots of each sample were diluted 1:5 with TE buffer (10
mM Tris, 1 mM EDTA) to a working concentration of 50
ng/μl. Four DNA pools were constructed in total. Three
independent pools were formed from the DNA of CEPH:
1) 'Mothers' (N = 29) 2) 'Fathers' (N = 30) and 3) 'Off-
spring' (N = 30) by combining equimolar amounts of
DNA from each individual (300 ng; 6 ul at 50 ng/μl). A
fourth 'Full' pool (N = 89) was formed by combining
equimolar amounts of each of the Mothers, Fathers and
Offspring DNA pools so that each individual sample con-
tributed 150 ng to the final pool; this equated to combin-
ing 87 μl of Mothers pool with 90 μl from the Fathers pool
and 90 μl from the Offspring pool.
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Genomic region selection
In order to investigate DNA pool performance, it was nec-
essary to decide upon genomic regions for DNA methyla-
tion analysis. To acheive a thorough assessment of the
accuracy of bisulfite-based profiling on pooled DNA sam-
ples it was desirable that we selected regions demonstrat-
ing considerable between-individual variation spanning a
range of DNA methylation levels from unmethylated to
fully methylated. Therefore we selected six regions nomi-
nated from ongoing studies in our laboratory (associated
with the genes DRD4, DAT1, ESR1, NR3C1, IGF2, and
SERT) that display high between-individual variability. As
well as inter-individual variation however, it was impor-
tant to select regions displaying variation in group aver-
ages when calculated from individual results, which
between-DNA pool comparison might serve to reflect.
With this in mind we selected three regions from the X
chromosome (associated with the genes AR, FMR1 and
MAOA). Assays were designed for these nine regions using
the online Sequenom EpiDesigner software http://
www.epidesigner.com, and oligo sequences are given in
Additional file 1.
DNA methylation analysis
Sodium bisulfite treatment was performed on 375 ng of
each individual sample and pool using the EZ-96 DNA
Methylation Kit (Zymo Research, CA, USA) following the
manufacturers' standard protocol. Bisulfite-PCR amplifi-
cation was conducted using Hot Star Taq DNA polymerase
(Qiagen, UK) and cycling conditions of 55 cycles with an
annealing temperature of 57°C for AR, and 45 cycles with
an annealing temperature of 56°C for all other ampli-
cions (see Additional file 1 for additional details about the
nine amplicons). DNA methylation analysis was con-
ducted following bisulfite-PCR amplification using the
Sequenom EpiTYPER system (Sequenom Inc, CA, USA) as
described previously [16]. This technique employs base-
specific cleavage followed by MALDI-TOF mass spectrom-
etry in which the size ratio of the cleaved products pro-
vides quantitative methylation estimates for CpG sites
within a target region [9]. The entire experiment, from
sodium bisulfite-treatment onwards, was subsequently
repeated in duplicate to control for technical variation,
and to assess the reliability of the data produced.
Statistical analysis
The accuracy of DNA methylation estimates generated
from pooled DNA was assessed via Pearson's product-
moment correlations with data averaged across the indi-
vidual samples comprising each pool. As some CpG sites
located within the same genomic region are in close phys-
ical proximity to each other, their DNA methylation levels
are unlikely to be entirely independent. We therefore fit a
linear mixed effects model to account for any possible
influence of such spatial correlations between CpG sites,
and implemented a bootstrapping technique – using sam-
pling with replacement – to estimate confidence intervals
on correlation coefficients.
Results and discussion
In total we assessed DNA methylation levels at 205 CpG
sites – assessed by the Sequenom EpiTYPER platform as
133 CpG units – across nine independent genomic
regions in each of the 89 CEPH individuals and four DNA
pools, with all analyses being performed in duplicate.
Comparison of data generated from the pooled DNA sam-
ples with results averaged across the individual samples
comprising each pool revealed highly significant correla-
tions (P < 2.2*10-16) for individual CpG sites across all
nine regions (see Table 1), which remained when a linear
mixed effects model was used to account for the spatial
correlation between CpG sites within each amplicon. The
overall correlation across all CpG sites assessed was 0.95
(95% bootstrapped confidence intervals: 0.94 to 0.96) in
the first replicate (see Figure 1A) and 0.95 (95% boot-
strapped confidence intervals: 0.93 to 0.96) in the second
replicate (see Figure 1B), with an overall correlation of
0.95 (95% bootstrapped confidence intervals: 0.94 to
0.96) across the averaged data from both replicates. This
correlation is comparable to the correlation of 0.95 seen
between technical replicates, that is, the results gathered
from the same individual samples in the first and second
replicates. Our analyses yielded similar results when each
of the DNA pools was assessed separately, demonstrating
no effect of overlap between individuals within each pool
on the overall correlation (see Table 2). Whilst virtually all
the pooled DNA methylation estimates correlated very
strongly with the group averages ascertained from profil-
ing individual samples, the overall performance of some
amplicons was better than others, suggesting that assay
design may be important. The lowest correlations are seen
in ESR1 – which may be explained by the fact that the first
round of reactions failed for this amplicon, so the esti-
mate is based on only one replicate. A linear mixed effects
model showed that pool type had no significant effect on
the overall correlations for a region. Furthermore, a range
of pool sizes were employed here to assist in determining
an ideal pool size for DNA methylation estimation. With
little difference in performance demonstrated (see Table
2) it would appear that pools of up to 89 individuals per-
form to the same high standard.
For those regions located on the X chromosome, the DNA
pool results clearly reflected the large sex differences in
DNA methylation expected as a result of X-inactivation in
females (Figure 2). Furthermore, the pooled DNA accu-
rately estimated group averages across even those regions
showing considerable between-individual variation (see
Figures 3 and 4). Remarkably, the average absolute differ-
ence between the 'pooled' DNA methylation estimate and
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Comparison of group average DNA methylation estimates obtained from pooled and individual DNA samples across 9 genomic regi nsFigure 1
Comparison of group average DNA methylation estimates obtained from pooled and individual DNA samples 
across 9 genomic regions. DNA methylation estimates across the 205 CpG sites obtained from pooled DNA samples are 
highly correlated with actual average DNA values obtained from individual DNA samples in both A) the first and B) the second 
technical replicates of this experiment.
Table 1: Correlations between pooled DNA methylation estimates and group averages assessed by individual sample analysis for CpG 
sites in each of the 9 genomic regions studied.
FMR1 DRD4 SERT IGF2 GR ESR1 DAT1 MAOA AR ALL
Individual average vs pool estimate – replicate 1 0.95 0.93 0.93 0.93 0.98 - 0.95 0.89 0.94 0.95
Individual average vs pool estimate – replicate 2 0.81 0.97 0.88 0.95 0.90 0.81 0.92 0.72 1.00 0.95
Individual data – replicate 1 vs replicate 2 0.83 0.97 0.93 0.95 0.87 - 0.94 0.93 0.94 0.95
Individual average vs pool estimate – average across both 
replicates
0.95 0.95 0.95 0.93 0.98 0.81 0.97 0.86 0.98 0.95
The overall correlation between the averaged individual data and the pooled estimate (0.95) is the same as that between replicates of the individual 
data (0.95).
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Table 2: Correlations between the methylation estimates, averaged across two replicates, of four DNA pools and group averages 
assessed by individual sample analysis for CpG sites in each of the nine genomic regions studied.
DNA pool n FMR1 DRD4 SERT IGF2 GR ESR1 DAT1 MAOA AR ALL
Mothers 29 0.93 0.86 0.96 0.94 0.99 0.88 0.98 0.91 0.99 0.93
Fathers 30 0.99 0.98 0.94 0.95 1.00 0.62 0.95 0.72 0.98 0.96
Offspring 30 0.95 0.98 0.98 0.96 0.99 0.88 0.98 0.91 0.97 0.96
Full 89 0.95 0.99 0.96 0.92 1.00 0.96 0.99 0.85 0.98 0.95
Group average DNA methylation estimates from pooled and individual DNA samples for the androgen receptor (AR) ampli-con on th  X-chromosomeFigure 2
Group average DNA methylation estimates from pooled and individual DNA samples for the androgen recep-
tor (AR) amplicon on the X-chromosome. Both the pool estimates and group averages based on individual DNA methyl-
ation data for the androgen receptor (AR) gene on the X chromosome clearly demonstrate the expected sex differences in 
DNA methylation with 'offspring' and 'total sample' pools (50% male, 50% female) showing intermediate levels of DNA methyl-
ation compared with the high level of methylation in the 'mothers' pool and low level of methylation in the 'fathers' pool.
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Amplicon-averaged data from the most variably methylated autosomal region (DRD4)Figure 3
Amplicon-averaged data from the most variably methylated autosomal region (DRD4). Blue diamonds denote 
DNA methylation for individual samples, green squares denote the pooled estimate, and red squares denote the average of the 
individual values for each group (total sample, offspring, mothers, and fathers). Even in this region, where individual DNA meth-
ylation values ranged from 40% to 91%, pooled estimates accurately predicted group averages.
Amplicon-averaged data from the most variably methylated X-chromosome region (AR)Figure 4
Amplicon-averaged data from the most variably methylated X-chromosome region (AR). Blue diamonds denote 
DNA methylation for individual samples, green squares denote the pooled estimate, and red squares denote the average of the 
individual values for each group (total sample, offspring, mothers, and fathers). Even in this region, where individual DNA meth-
ylation values ranged from 7% to 88%, pooled estimates accurately predicted group averages.
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the 'real' average, determined by assessing individual sam-
ples, was 6.0% in the first set of experiments and 4.8% in
the second set of replicates. This approximates to the nor-
mal level of between-replicate variability expected using
the Sequenom EpiTYPER approach [9] and suggests that
the accurate pooling of DNA prior to sodium bisulfite
treatment does not introduce any significant error beyond
that resulting from normal technical variability.
Our data indicate that the DNA methylation profiles
obtained from pooled genomic DNA samples are remark-
ably consistent with those obtained from averaging the
values for individual samples in a group, even in large
pools of individual samples and for regions of the genome
demonstrating high levels of between-individual DNA
methylation variation. Obtaining methylation data from
DNA pools could be extremely useful in instances where
the availability of DNA from valuable sample collections
is low, or where it is unfeasible to apply the desired profil-
ing methodology to large numbers of samples. In such
cases, it may be desirable to screen group averages using
pooled DNA, in order to identify interesting regions war-
ranting further investigation on an individual sample
basis. While we assessed the validity of DNA pooling for
DNA methylation profiling using the Sequenom EpiTY-
PER mass-spectrometry system, this method is potentially
applicable to all bisulfite-based mapping techniques.
Combined with microarrays and next-generation deep-
sequencing technologies, for example, the bisulfite-based
assessment of pooled genomic DNA should enable high-
resolution methylation profiling to be performed across
the large sample sizes required for detecting epimutations
associated with pathological conditions. The utility of
pooled genomic DNA in combination with high-resolu-
tion bisulfite mapping on next-generation sequencing
platforms was highlighted by a recent study on pooled
leukemia samples [10], and our data suggest that the con-
clusions from such studies are likely to be valid. This
approach should facilitate the high-throughput assess-
ment of disease phenotypes, reducing the time, cost and
amount of DNA starting material required for large-scale
epigenetic analyses.
Conclusion
Compared with data generated from 89 individual sam-
ples, our analysis of 205 CpG sites spanning nine inde-
pendent regions of the genome demonstrates that DNA
pools can be used to provide an accurate and reliable
quantitative estimate of average group DNA methylation
using the Sequenom EpiTYPER system. Such an approach
may be especially useful in highlighting regions of the
genome for further analysis in large-scale epigenetic
assessment of disease phenotypes – reducing the time,
cost and amount of DNA starting material required.
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